The response of human ectomesenchymal dental pulp stem cells to cisplatin treatment

被引:36
作者
Seifrtova, M. [1 ]
Havelek, R. [1 ]
Cmielova, J. [1 ]
Jiroutova, A. [1 ]
Soukup, T. [2 ]
Bruckova, L. [3 ]
Mokry, J. [2 ]
English, D. [4 ]
Rezacova, M. [1 ]
机构
[1] Charles Univ Prague, Dept Med Biochem, Prague, Czech Republic
[2] Charles Univ Prague, Dept Histol & Embryol, Fac Med Hradec Kralove, Prague, Czech Republic
[3] Univ Pardubice, Dept Analyt Chem, Fac Chem Technol, Pardubice, Czech Republic
[4] Florida Fdn Dev Res, Palmetto, FL USA
关键词
apoptosis; cisplatin; dental pulp stem cells; human dermal fibroblasts; Mitogen-activated protein kinases; p53; ACTIVATED PROTEIN-KINASES; OVARIAN-CARCINOMA CELLS; LONG-TERM CULTURE; SPONTANEOUS DIFFERENTIATION; CHEMOTHERAPEUTIC-AGENTS; INDUCED APOPTOSIS; CANCER-CELLS; P53; DNA; SENSITIVITY;
D O I
10.1111/j.1365-2591.2011.01990.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Aim To determine the response of dental pulp stem cells (DPSCs) to DNA-damaging cytostatic cisplatin and compare it with the response of normal human dermal fibroblasts (HDFs). Methodology Dental pulp stem cells were exposed to 5, 10, 20 or 40 mu mol L-1 of cisplatin. The proliferation of affected cells was assessed by a Z2 Counter and viability was assessed by means of a Vi-Cell XR using Trypan blue exclusion staining. Cell cycle analysis and induction of apoptosis were performed by flow cytometry. Induction of apoptosis was determined by monitoring the activities of caspases. The expression of proteins was detected by electrophoresis and Western blotting. The descriptive statistics of the results was analyzed by Students t-test. Results Dental pulp stem cells had a greater genotoxic stress response to cisplatin compared to HDFs. All three main Mitogen-activated protein kinases (MAPK) families extracellular signal-regulated kinases (ERK), c-Jun-N-terminal kinase (JNK) and p38 were activated after treatment of DPSCs with cisplatin. The activation of MAPK pathways was not observed in HDFs exposed to cisplatin. The exposure of DPSCs and HDFs to cisplatin provoked an increase in p53 and p21 expression and p53 phosphorylation of serine 15. Higher concentrations of cisplatin reduced the viability of DPSCs and HDFs and induced the activation of caspases 3/7 and 9. Conclusion Dental pulp stem cells had a greater genotoxic stress response to cisplatin compared to HDFs. Cisplatin in higher concentrations triggered activation of MAPK and apoptosis in DPSCs but not in HDFs.
引用
收藏
页码:401 / 412
页数:12
相关论文
共 39 条
[1]   The p53 network [J].
Agarwal, ML ;
Taylor, WR ;
Chernov, MV ;
Chernova, OB ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :1-4
[2]   Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues [J].
Arthur, Agnes ;
Rychkov, Grigori ;
Shi, Songtao ;
Koblar, Simon Andrea ;
Gronthos, Stan .
STEM CELLS, 2008, 26 (07) :1787-1795
[3]   Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance [J].
Brozovic, Anamaria ;
Osmak, Maja .
CANCER LETTERS, 2007, 251 (01) :1-16
[4]  
CHU G, 1994, J BIOL CHEM, V269, P787
[5]   What has senescence got to do with cancer? [J].
Dimri, GP .
CANCER CELL, 2005, 7 (06) :505-512
[6]  
FAN SJ, 1995, CANCER RES, V55, P1649
[7]   Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard [J].
Fan, SJ ;
Chang, JK ;
Smith, ML ;
Duba, D ;
Fornace, AJ ;
OConnor, PM .
ONCOGENE, 1997, 14 (18) :2127-2136
[8]   Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response [J].
Golding, Sarah E. ;
Rosenberg, Elizabeth ;
Neill, Steven ;
Dent, Paul ;
Povirk, Lawrence F. ;
Valerie, Kristoffer .
CANCER RESEARCH, 2007, 67 (03) :1046-1053
[9]   Is cisplatin-induced cell death always produced by apoptosis? [J].
Gonzalez, VM ;
Fuertes, MA ;
Alonso, C ;
Perez, JM .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :657-663
[10]   Constancy in integrated cisplatin plasma concentrations among pediatric patients [J].
Goodisman, J ;
Souid, AK .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (04) :443-448